RecruitingPhase 1NCT06947304

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Studying Disorder of lipid metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Corcept Therapeutics
Principal Investigator
Kavita Juneja, MD, md
Corcept Therapeutics
Intervention
Miricorilant(drug)
Enrollment
8 target
Eligibility
18-75 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

University of Missouri-Columbia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06947304 on ClinicalTrials.gov

Other trials for Disorder of lipid metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of lipid metabolism

← Back to all trials